Total Payments
$2,978
2024 Payments
$412.79
Companies
22
Transactions
115
Medicare Patients
7,750
Medicare Billing
$586,578
Payment Breakdown by Category
Food & Beverage$2,883 (96.8%)
Education$94.99 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,883 | 114 | 96.8% |
| Education | $94.99 | 1 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $803.56 | 40 | $0 (2024) |
| Merz North America, Inc. | $261.15 | 7 | $0 (2019) |
| PFIZER INC. | $222.20 | 7 | $0 (2021) |
| REVANCE THERAPEUTICS, INC. | $182.85 | 2 | $0 (2024) |
| MAYNE PHARMA INC. | $179.79 | 9 | $0 (2020) |
| Incyte Corporation | $163.69 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $160.43 | 7 | $0 (2022) |
| GENZYME CORPORATION | $142.59 | 3 | $0 (2019) |
| PruGen, Inc. Pharmaceuticals | $136.68 | 2 | $0 (2019) |
| Biofrontera Inc. | $132.36 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $412.79 | 12 | REVANCE THERAPEUTICS, INC. ($182.85) |
| 2023 | $171.18 | 5 | Incyte Corporation ($94.99) |
| 2022 | $202.20 | 9 | Sun Pharmaceutical Industries Inc. ($46.59) |
| 2021 | $145.36 | 8 | Galderma Laboratories, L.P. ($47.88) |
| 2020 | $89.83 | 5 | Galderma Laboratories, L.P. ($29.08) |
| 2019 | $613.08 | 22 | Merz North America, Inc. ($141.50) |
| 2018 | $455.04 | 23 | Merz North America, Inc. ($99.06) |
| 2017 | $888.93 | 31 | Galderma Laboratories, L.P. ($421.63) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $25.71 | General |
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.01 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.14 | General |
| 06/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), ARAZLO, JUBLIA | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Dermatology | ||||||
| 05/30/2024 | REVANCE THERAPEUTICS, INC. | DAXI (Drug) | Food and Beverage | In-kind items and services | $139.51 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/29/2024 | Musculoskeletal Transplant Foundation Inc. | — | Food and Beverage | In-kind items and services | $36.51 | General |
| 04/23/2024 | REVANCE THERAPEUTICS, INC. | — | Food and Beverage | In-kind items and services | $43.34 | General |
| 04/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.59 | General |
| Category: Dermatology | ||||||
| 01/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.09 | General |
| 10/10/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.59 | General |
| 08/15/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.16 | General |
| 06/21/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.81 | General |
| 04/27/2023 | Incyte Corporation | — | Education | Cash or cash equivalent | $94.99 | General |
| 03/08/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.63 | General |
| 11/29/2022 | Galderma Laboratories, L.P. | EPSOLAY (Drug), ORACEA | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: ROSACEA | ||||||
| 09/13/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.83 | General |
| Category: Dermatology | ||||||
| 09/07/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: IMMUNOLOGY | ||||||
| 08/25/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Dermatology | ||||||
| 07/27/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.28 | General |
| Category: Dermatology | ||||||
| 07/21/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology | ||||||
| 06/23/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: DERMATOLOGY | ||||||
| 05/18/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.01 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 678 | 1,017 | $94,250 | $39,604 |
| 2022 | 11 | 942 | 1,327 | $139,447 | $62,370 |
| 2021 | 23 | 3,062 | 8,949 | $548,153 | $236,566 |
| 2020 | 23 | 3,068 | 9,655 | $553,665 | $248,038 |
Total Patients
7,750
Total Services
20,948
Medicare Billing
$586,578
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 246 | 280 | $39,253 | $16,611 | 42.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 113 | 122 | $19,231 | $8,303 | 43.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 116 | 136 | $14,210 | $4,549 | 32.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 44 | 47 | $8,272 | $4,001 | 48.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 46 | 50 | $4,388 | $2,066 | 47.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 35 | 47 | $3,677 | $1,882 | 51.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 67 | 324 | $3,289 | $1,639 | 49.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,930 | $552.49 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 325 | 380 | $54,192 | $25,006 | 46.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 143 | 160 | $25,851 | $11,509 | 44.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 148 | 170 | $18,103 | $6,718 | 37.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 73 | 79 | $14,113 | $6,285 | 44.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 71 | 79 | $7,058 | $3,203 | 45.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 33 | 57 | $4,603 | $2,358 | 51.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 11 | 15 | $4,243 | $1,972 | 46.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 91 | 340 | $3,536 | $1,800 | 50.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $3,926 | $1,625 | 41.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 11 | $2,210 | $1,185 | 53.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $1,612 | $708.73 | 44.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 746 | 1,111 | $159,317 | $68,884 | 43.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 397 | 504 | $81,837 | $35,072 | 42.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 495 | 700 | $72,516 | $26,786 | 36.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 191 | 221 | $39,266 | $17,754 | 45.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 315 | 424 | $37,286 | $16,676 | 44.7% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 41 | 45 | $21,947 | $10,304 | 47.0% |
About Dr. Shauna Kranendonk, M.D
Dr. Shauna Kranendonk, M.D is a Procedural Dermatology healthcare provider based in Jupiter, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659316867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shauna Kranendonk, M.D has received a total of $2,978 in payments from pharmaceutical and medical device companies, with $412.79 received in 2024. These payments were reported across 115 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,883).
As a Medicare-enrolled provider, Kranendonk has provided services to 7,750 Medicare beneficiaries, totaling 20,948 services with total Medicare billing of $586,578. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Location Jupiter, FL
- Active Since 06/19/2006
- Last Updated 02/05/2014
- Taxonomy Code 207NS0135X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659316867
Products in Payments
- EUCRISA (Drug) $222.20
- DORYX (Drug) $179.79
- COSENTYX (Biological) $160.43
- SOOLANTRA (Drug) $153.07
- DAXI (Drug) $139.51
- EPIDUO FORTE (Drug) $125.60
- Ameluz (Drug) $106.54
- ATOPIC DERMATITIS - DISEASE (Drug) $97.95
- ORACEA (Drug) $85.95
- ENSTILAR (Drug) $69.46
- OPZELURA (Drug) $68.70
- TALTZ (Drug) $64.33
- SKYRIZI (Biological) $53.77
- XEOMIN (Biological) $48.61
- ILUMYA (Biological) $46.59
- DUPIXENT (Drug) $44.64
- KYBELLA (Biological) $43.86
- REMICADE (Biological) $37.87
- Finacea (Drug) $34.97
- AMELUZ (Drug) $25.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.